Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.17
-0.04 (-0.77%)
At close: Apr 28, 2026, 4:00 PM EDT
5.17
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $303.48 million as of April 28, 2026. Its market cap has increased by 68.95% in one year.
Market Cap
303.48M
Enterprise Value
186.44M
1-Year Change
68.95%
Ranking
Category
Stock Price
$5.17
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $303.48M, a decrease of -46.33%. That is a compound annual growth rate of -10.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 328.15M |
| Nautilus Biotechnology | 325.27M |
| Cabaletta Bio | 323.95M |
| Compass Therapeutics | 322.36M |
| Inhibikase Therapeutics | 322.15M |
| NervGen Pharma | 311.58M |
| LENZ Therapeutics | 306.02M |
| Anavex Life Sciences | 304.89M |